RUA Life Sciences PLC Grant of Share Options (5868J)
13 Diciembre 2022 - 9:43AM
UK Regulatory
TIDMRUA
RNS Number : 5868J
RUA Life Sciences PLC
13 December 2022
13 December 2022
RUA Life Sciences Plc
("RUA Life Sciences", the "Company" or the "Group")
Grant of EMI Share Options
RUA Life Sciences, the holding company of a group of medical
device businesses focused on the exploitation of the patented
long-term implantable biostable polymer, Elast-Eon(TM) , announces
that it has granted, in aggregate, 240,000 share options over
ordinary shares of GBP0.05 ("Ordinary Shares") (the "Options") to
executive Directors of the Group, as detailed below.
120,000 Options have been awarded to each of Lachlan Smith,
Chief Financial Officer, and Iain Anthony, Director of Clinical and
Regulatory Affairs and a board director of the Company. The Options
are issued under the Company's EMI Share Option Plan as summarised
in Part IV of the Company's circular dated 22 May 2018 and approved
by shareholders at the Company's general meeting on 8 June 2018
(the "Scheme").
The exercise price of the Options is 44.5 pence per share,
representing the closing mid-market price per Ordinary Share on the
day preceding the release of this announcement.
The key vesting terms are that the options may not be exercised
before the third anniversary of grant. In addition, performance
conditions apply such that 50% of the Options may only be exercised
if the Company has received regulatory approval for at least one
medical device and the company continues to exploit one such
device. The performance condition for the balance of the Options is
based on total shareholder return with full vesting achieved at 50%
annualised return and a minimum of the median performance of the
constituents of the FTSE AIM index. If the Option holder ceases to
be a director or employee of the Company as appropriate after the
relevant vesting date, the Options lapse 90 days after cessation
unless the Board resolves to allow exercise within that period.
Including the new 240,000 Options, the Company has outstanding
awards over 2,280,603 Ordinary Shares, representing approximately
10.3% of the Company's current issued share capital.
For further information contact:
RUA Life Sciences
Bill Brown, Chairman Tel: +44 (0)1294 317073
Caroline Stretton, Group Managing Director Tel: +44 (0)1294 317073
Cenkos Securities plc (Nominated Adviser and Broker) Tel: +44 (0)20 7397 8900
Giles Balleny / Max Gould (Corporate Finance)
Michael Johnson (Sales)
About RUA Life Sciences
The RUA Life Sciences group was created in April 2020 when RUA
Life Sciences Plc (formerly known as AorTech International Plc)
acquired RUA Medical Devices Limited to create a fully formed
medical device business. RUA Life Sciences is the holding company
of the Group's four trading businesses, each exploiting the Group's
patented polymer technology.
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================
a) Name Lachlan Smith
==== ================================== ===========================================
b) Position/status CFO / PDMR
==== ================================== ===========================================
c) Initial notification/ Initial notification
amendment
==== ================================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================
a) Name RUA Life Sciences plc
==== ================================== ===========================================
b) LEI 213800BMVB22PVOJ9Z28
==== ================================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================
a) Description of the Ordinary shares of 5 pence each
financial instrument ISIN: GB0033360586
==== ================================== ===========================================
b) Nature of the transaction Award of Options over Ordinary Shares.
==== ================================== ===========================================
c) Price(s) and volume(s) Exercise Price(s) Volume(s)
==== ================================== ========================= =============
44.5p 120,000
========================= =============
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
=================================== ===============================================
e) Date of the transaction 13 December 2022
==== ================================== ===========================================
f) Place of the transaction UK
==== ================================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ====================================================================================
a) Name Ian Anthony
==== ================================== ================================================
b) Position/status Director of Clinical and Regulatory Affairs
/ PDMR
==== ================================== ================================================
c) Initial notification/ Initial notification
amendment
==== ================================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ====================================================================================
a) Name RUA Life Sciences plc
==== ================================== ================================================
b) LEI 213800BMVB22PVOJ9Z28
==== ================================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ====================================================================================
a) Description of the Ordinary shares of 5 pence each
financial instrument ISIN: GB0033360586
==== ================================== ================================================
b) Nature of the transaction Award of Options over Ordinary Shares.
==== ================================== ================================================
c) Price(s) and volume(s) Exercise Price(s) Volume(s)
==== ================================== ============================= ==============
44.5p 120,000
============================= ==============
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
=================================== ====================================================
e) Date of the transaction 13 December 2022
==== ================================== ================================================
f) Place of the transaction UK
==== ================================== ================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEASADFLFAFFA
(END) Dow Jones Newswires
December 13, 2022 10:43 ET (15:43 GMT)
Rua Life Sciences (LSE:RUA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Rua Life Sciences (LSE:RUA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
